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Abstract
Conduct disorder (CD) symptoms co-occur at high rates with illicit drug use in juvenile justice 
involved youth, which results in poorer outcomes; however, research has not identified where best 
to intervene in this relationship, limiting the identification of modifiable risk factors to reduce 
negative effects of CD symptoms. Two mediation models were examined to investigate the 
potential for CD symptoms to influence a reciprocal relationship between illicit drug use and 
positive drug attitudes, controlling for age, gender, and race. Data were examined for 245 juvenile 
justice involved youth (mean age=15.46, SD=1.30, range 12-18, 64.9% black, 80.4% male) who 
completed court-ordered psychological assessments. Findings indicate: 1) Positive attitudes toward 
illicit drug use significantly mediated the relationship between CD symptoms and illicit drug use 
(β=0.16, CI 0.09 to 0.27; Test for indirect effect z=4.17, p<.001); and 2) illicit drug use 
significantly mediated the relationship between CD symptoms and positive attitudes toward illicit 
drug use (β=0.20, CI 0.12 to 0.32; Test for indirect effect z=4.87, p<.001). Overall, the present 
study suggests that CD symptoms impart risk for illicit drug use both indirectly, through more 
positive attitudes toward illicit drug use, and directly, which further strengthens positive attitudes 
toward illicit drug use.
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1. Introduction
Juvenile justice involved youth report high rates of illicit drug use, with approximately 42% 
meeting criteria for a cannabis use disorder and approximately 20% meeting criteria for 
polysubstance use disorder (Teplin et al., 2002). Further, juvenile justice involved youth that 
use illicit drugs are more likely to face negative outcomes, including criminal recidivism 
*
 Corresponding Author alermart@iupui.edu, 317-274-6943 (p), 402 North Blackford Street, Indianapolis, IN, 46202. 
HHS Public Access
Author manuscript
Subst Use Misuse. Author manuscript; available in PMC 2019 January 03.
Published in final edited form as:
Subst Use Misuse. 2018 July 03; 53(8): 1252–1259. doi:10.1080/10826084.2017.1402058.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
(Wilson et al., 2001), increased risk for violent crime (Beck and Wencel, 1998), and 
increased risk for substance use problems in later adolescence and adulthood (Prinz and 
Kerns, 2003). One risk factor for illicit drug use, particularly in this high-risk population, is 
conduct disorder (CD; Hopfer et al., 2013)
Research indicates approximately 53% of juvenile justice involved youth meet criteria for 
CD (Fazel, Doll, & Langstrom, 2008). This is particularly troubling, as a CD diagnosis is 
associated with a host of negative outcomes, including criminal recidivism (Boduszek, 
Belsher, & Dhingra, 2014), development of antisocial personality disorder (Loeber, Burke, 
Lahey, Winters, & Zera, 2000), and increased risk for committing violent crimes (Hodgins, 
Cree, Alderton, & Mak, 2008). Further, CD co-occurs with illicit drug use, which imparts 
additional risk for poor outcomes, such as antisocial behavior and impulsivity (Dalwani et 
al., 2014). Importantly, while a diagnosis of CD is associated with illicit drug use and related 
problems, research indicates that continuous measures of CD symptoms (e.g. delinquency, 
aggression) have more robust associations with higher rates of substance use disorders 
(SUDs), more illicit drug use and abuse (Hayatbakhsh et al., 2008), and increased risk for 
long-term drug use and related problems (e.g., Pedersen, Mastekaasa, & Wichstrom, 2001; 
Fergusson, Horwood, & Ridder, 2007). Thus, it appears that as CD symptoms increase, so 
does associated illicit substance use; however limited research has examined why or how CD 
symptoms and illicit drug use are related in juvenile justice involved youth, which makes it 
unclear how best to intervene to reduce risks associated with CD symptoms and illicit drug 
use.
On one hand, attitudes towards illicit drug use are a prime potential mediator of the 
relationship between CD symptoms and illicit drug use. Youth with more CD symptoms 
likely have more positive attitudes towards drug use, compared to youth with fewer CD 
symptoms. For example, the Acquired Preparedness model posits that factors, such as 
personality traits, predispose individuals to develop specific beliefs, attitudes, and 
expectancies of their environment, such as positive attitudes or expectancies of substance 
use, which, in turn, increase the individual’s risk for substance use (Smith & Anderson, 
2001). Longitudinal research supports the Acquired Preparedness model (e.g., Settles, 
Cyders, & Smith, 2010), by which personality leads to beliefs about substance use and, 
ultimately, substance use. Additionally, previous research has supported that the onset of CD 
symptoms occurs prior to the onset of SUDs, further supporting attitudes towards illicit drug 
use as a potential mediator of the relationship between CD symptoms and illicit drug use 
(e.g., Guldager, Linneberg, & Hesse, 2012; Stone, Vander Stoep, & McCauley, 2016). 
Additionally, although there is limited research in juvenile justice involved youth 
populations, community youth literature indicates a positive relationship between illicit drug 
use attitudes and illicit drug use (e.g. Miller, Chomcynova, & Beck, 2009; Como-Lesko, 
Primavera, & Szeszko, 1994; Danseco, Kingery, & Coggeshall, 1999). Research also 
indicates that positive attitudes towards drug use in childhood precede onset of drug use (e.g. 
Fisher, Miles, Austin, Carmargo, & Colditz, 2007; Guller, Zapolski, & Smith, 2015; Wright, 
Fagan, & Pinchevsky, 2016). Identifying modifiable mechanisms in the CD symptoms and 
illicit drug use relationship in juvenile justice involved youth may aid in increasing positive 
treatment outcomes. Positive drug attitudes are a modifiable risk factor that could be targeted 
in order to reduce the effects of CD symptoms on illicit drug use. For example, one strategy 
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of motivational interviewing skills, identifying pros and cons of a behavior, can be used to 
identify youth’s positive attitudes towards drug use, which could be impeding their 
motivation to change. Employing skills to challenge these positive attitudes would thus 
improve treatment outcomes.
On the other hand, illicit drug use may also mediate the relationship between CD symptoms 
and positive drug attitudes. Drugs of abuse provide a rewarding experience via the 
mesolimbic dopamine system (e.g. Huibing, Rosen, Ng, Rushlow, & Laviolette, 2014; 
Walker, Cates, Heller, & Nestler, 2015), with dopaminergic positive reinforcement, 
combined with learning processes (e.g. experiences) likely strengthening positive attitudes 
towards drug use (e.g. “drug use makes me creative”; Miller, Renn, & Lazowski, 2001). 
Additionally, youth with CD symptoms appear to have an altered neurological reward 
system, with research indicating that these youth have a heightened reward experience 
(Fairchild et al. 2009), further increasing the likelihood that youth with higher CD symptoms 
experience reward from drugs of abuse, and thus develop positive attitudes towards drug use. 
Intervening on drug use, particularly the rewarding experience of drug use, is one factor that 
can be targeted in order to reduce the impact that CD symptoms have on positive drug use 
attitudes. For example, contingency management, an incentive-based treatment for substance 
use, can be used to reward drug abstinence, with the goal of diminishing the reward of drug 
use. Although the data are somewhat limited in juvenile justice involved youth, there is 
preliminary evidence that combined contingency management and family engagement 
strategies within juvenile drug courts reduce drug use and improve outcomes for juvenile 
justice involved youth (Henggeler, McCart, Cunningham, & Chapman, 2012). At the same 
time, targeting drug use as a mechanism in the relationship between CD symptoms and 
positive drug use attitudes may better lend itself to prevention, rather than intervention 
strategies. For example, research indicates that school-based prevention programs, 
particularly those targeting social competence and using social norms approaches, show 
some efficacy in preventing drug use (see Faggiano et al., 2014 for a review).
Research, to-date, has yet to examine how CD symptoms might distally influence the 
relationship between illicit drug use attitudes and illicit drug use in juvenile justice involved 
youth. Determining the direction of this relationship has clinical implications, as it would 
inform where best to intervene to reduce the influence of CD symptoms on illicit drug use – 
i.e., should we target drug attitudes, illicit drug use itself, or both? Therefore, the goal of the 
current study was to provide the initial test of these models. We examined two alternative, 
although not mutually exclusive, models: 1) The relationship between CD symptoms and 
illicit drug use as mediated by positive attitudes toward illicit drug use and 2) the 
relationship between CD symptoms and positive attitudes toward illicit drug use as mediated 
by illicit drug use. Although our data are cross-sectional in nature, examination can supply 
initial evidence to support feasibility and viability of examining these models in subsequent 
temporal research, which would not be warranted without first establishing relationships 
using cross-sectional approaches.
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2. Materials and Methods
2.1 Participants
Data were taken from existing charts of 305 juvenile justice involved youth who were 
detained and court ordered to complete a psychological assessment between 2009 and 2016. 
Youth completed integrated assessments and a subset of that data are included in the current 
report. Data were de-identified and analysis of these archival data was approved by the 
Institutional Review Board.
2.2 Materials
2.2.1 Demographics—Youth self-reported their age, gender (male or female), and race.
2.2.2 Conduct Disorder Symptoms—(CD symptoms) were assessed via the Youth 
Self-Report Conduct Problems Scale (Achenbach & Rescorla, 2001). The Youth Self-Report 
(YSR) is a self-report assessment in which youth rate themselves on various behavioral and 
emotional problems and competencies. Response options range from 0 (not true) to 2 (very 
often or often true) and scale scores are then converted to t-scores with corresponding 
percentiles. For the Conduct Problems scale, which we used to assessed CD symptoms (e.g., 
“I destroy things belonging to others,” “I don’t feel guilty after doing something I 
shouldn’t”), t-scores < 65 are considered to fall in the “normal” range, and increases in t-
scores over 65 correspond with increases in symptom severity. Scores on the Conduct 
Problems scale show good correspondence with CD diagnoses (r=0.85; Collins, 2016). 
Additionally, the YSR has shown good reliability (Ebesutani, Berstein, Martinez, & 
Chorpita, 2011), has been validated for use in samples of juvenile justice involved youth 
(Vreugdenhil et al., 2006), and correlates well with personality measures of antisocial 
behavior (e.g., Krischer et al., 2007). This measure of CD symptoms was used as the 
independent variable in study analyses.
Conduct Disorder diagnosis (distinct from our measure of CD symptoms) was made by a 
licensed clinical psychologist conducting or supervising each youth’s assessment. Diagnoses 
were based on a structured clinical interview and YSR correspondence with DSM-IV-TR 
(American Psychiatric Association, 2000) or DSM-5 (American Psychiatric Association, 
2013) Conduct Disorder diagnostic criteria (version used based on date of assessment; no 
changes to diagnostic criteria between versions of the DSM with the exception of the 
qualifier “with limited prosocial emotions”, which was not examined in the present study). 
CD diagnosis was used as a descriptive measure for the present study.
2.2.3 Illicit drug use and attitudes towards illicit drug use—Illicit drug use and 
attitudes towards illicit drug use were assessed through the Adolescent Substance Use Subtle 
Screening Inventory (SASSI-A2; Miller et al., 2001). The SASSI-A2 is a psychological 
screening questionnaire designed to help determine if an adolescent is in need of further 
assessment and possible treatment for having a substance use disorder (i.e., substance 
dependence or substance abuse). Results are provided as t-scores based on norms derived 
from an adolescent sample (mean age = 15, SD = 1.9) across addiction treatment centers, 
inpatient psychiatric hospitals, outpatient behavioral health facilities, and juvenile 
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corrections programs. The SASSI-A2 has demonstrated good validity, showing relationships 
with MMPI-A substance use scales (Choi et al., 2012), as well as good reliability (Perera-
Diltz & Perry, 2011). The present study examined select scales of the SASSI-A2 relevant to 
the current study.
2.2.3.1 Illicit drug use: In order to investigate illicit drug use, the Face Valid Other Drugs 
(FVOD) scale of the SASSI-A2 was used, which assesses behaviors related to illicit drug use 
(e.g. “Taken drugs to improve your thinking and feeling”, “Taken drugs so you could enjoy 
sex more”; Miller et al., 2001). The FVOD scale has shown high internal consistency (α = 
0.95) and test-retest reliability (α = 0.92), and aids in correctly classifying adolescents with 
a drug use related disorder (Miller & Lazowski, 2001).
2.2.3.2 Illicit drug use attitudes: Illicit drug use attitudes were assessed through the 
SASSI-A2 Attitudes scale, which assesses youth’s beliefs and attitudes towards illicit drug 
use (e.g. “Adults shouldn’t hassle kids so much about drugs”, “Drugs help people to be 
creative”; Miller et al., 2001). The Attitudes scale has been shown to have good reliability (α 
= 0.76; Miller et al., 2001; Perera-Diltz & Perry, 2011) and test-retest reliability (α = 0.92) 
and has been validated for use in discriminating between individuals with and without a 
SUD (Lewis & Mobley, 2010).
2.3 Procedure
Following involvement with the Juvenile Court (e.g. arrested, probation violation), youth in 
the present sample were referred to complete a court ordered psychological assessment. 
After referral, a licensed clinical psychologist or supervised doctoral student reported to the 
Juvenile Detention Center or the youth’s current placement (e.g. residential facility, home) 
to complete the assessment. Clinicians conducted a structured clinical interview and 
administered an assessment battery, which included the YSR, SASSI-A2, and other 
measures unrelated to the present study. The clinician composed an integrated report for 
each youth, which was submitted to the Juvenile Court. Trained research assistants coded 
and de-identified the integrated reports for each youth. Institutional Review Board approval 
was received to analyze these de-identified data. An additional research assistant re-coded 
20% of the data; there were no discrepancies found between coders.
2.4 Data Analysis Plan
First, we examined sample characteristics. Second, we examined two mediation models 
using Andrew Hayes’ PROCESS macro (Hayes, 2013), controlling for age, gender, and race 
(dichotomized as “White” and “Non-White” to improve power). In the first model, CD 
symptoms was entered as the independent variable, illicit drug use was entered as the 
dependent variable, and positive attitudes toward illicit drug use was entered as the mediator. 
In the second model, CD symptoms was entered as the independent variable, positive 
attitudes toward illicit drug use was entered as the dependent variable, and illicit drug use 
was entered as the mediator.
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3. Results
3.1 Descriptive Statistics
Of the 305 youth completing court-ordered psychological assessments, 245 were assessed 
for CD symptoms (using the YSR Conduct Problems scale), illicit drug use, and positive 
attitudes towards illicit drug use (both by using the SASSI-A2), making the final sample 245 
youth (mean age = 15.46, SD = 1.30, range 12-18; 80.4% males; 22.04% White, 89.1% 
Black, 4.8% Hispanic or Latino, 6.06% multiracial youth). Youth that were not administered 
the YSR and SASSI-A2 were significantly younger (t(303) = 2.65, p = .008), more likely to 
be female (χ2 = 4.20, p = .04) and less likely to have a cannabis use disorder diagnosis (χ2 
= 11.39, p = .001). Those that did and did not complete these measures did not differ 
significantly by race (χ2 = 7.93, p = 0.24) or other illicit drug use disorder diagnoses (e.g. 
stimulant use disorder; χ2 = 0.02, p = 0.88). The majority of the assessments were 
conducted at the juvenile detention center (85.3%), with others being conducted in the 
youth’s current placement (e.g. residential treatment). Youth’s had an average of 6.60 (SD = 
4.12) criminal referrals to the court. Table 1 provides descriptive statistics for the final 
sample.
Of the 245 youth, 40.8% were diagnosed with CD, 42.9% were diagnosed with a cannabis 
use disorder, and 1.6% were diagnosed with another illicit drug use disorder (e.g. stimulant 
use disorder) by a licensed clinical psychologist. The average score on the Face Valid Other 
Drugs scale of the SASSI-A2 was 55.60 (SD = 12.10; range 6 – 96), the average score on 
the Attitudes scale of the SASSI-A2 was 51.41 (SD = 10.75; range 7 – 80), the average CD 
symptoms score from the YSR was 64.24 (SD = 10.01; range 50 – 97), and all scales were 
approximately normally distributed. Of youth scoring >70 (clinical range) on CD symptoms 
54.7% were diagnosed with CD by a licensed clinical psychologist. CD symptoms (and not 
CD diagnosis) was used in study analyses due to its correspondence with DSM CD 
diagnoses and to capture variability in scores on conduct-related problems. Table 2 provides 
correlations among study variables.
3.2 Mediation Analyses
CD symptoms were significantly related to positive attitudes toward illicit drug use (β = 
0.38, p < .001) and these positive attitudes were significantly related to illicit drug use (β = 
0.42, p < .001). The indirect effect was significant (β = 0.16, CI 0.09 to 0.27; Test for 
indirect effect z = 4.17, p < .001; Figure 1, top). CD symptoms were significantly related to 
illicit drug use (β = 0.56, p < .001) and illicit drug use was significantly related to positive 
attitudes toward illicit drug use (β = 0.37, p < .001). The indirect effect was significant (β = 
0.20, CI 0.12 to 0.32; Test for indirect effect z = 4.87, p < .001; Figure 1, bottom).
4. Discussion
Juvenile justice involved youth face a disproportionate amount of negative outcomes 
compared to their same age peers (e.g., Hershberger et al., 2016; Fazel et al., 2008), 
specifically negative outcomes related to drug use (e.g. Pedersen, Mastekaasa, & Wichstrom, 
2001; Fergusson, Horwood, & Ridder, 2007), highlighting the need to better reduce and 
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prevent illicit drug use in this high risk group. The present study suggests that CD symptoms 
in juvenile justice involved youth impart risk for illicit drug in two ways: 1) indirectly, 
through the endorsement of more positive attitudes toward illicit drug use, and 2) directly, 
which then further strengthens positive attitudes toward illicit drug use. Overall, these 
findings suggest that in order to reduce the effect of CD symptoms in this high-risk group, 
interventions should target both illicit drug use itself and positive attitudes associated with 
such drug use. Further, given the limited financial and treatment resources of the juvenile 
justice system, and inconclusive evidence of the cost-effectiveness of other well-supported 
treatments of juvenile justice involved youth (Goorden et al., 2016), the present study 
suggests that providing targeted, and quite feasible, treatment aimed at changing positive 
attitudes and mitigating the rewarding experience of drug use could help diminish the impact 
of CD symptoms on substance use.
CD symptoms are related to illicit drug use symptomology in juvenile justice involved youth 
(Hayatbakhsh et al., 2008) and the current study is the first to suggest that this relationship is 
mediated by positive drug attitudes and likely contributes to positive drug attitudes. 
Although the present study was cross-sectional, we view these findings as a key first step in 
a program of research to determine how best to reduce the negative effects of CD symptoms 
for juvenile justice involved youth, which supports the future analysis of this work in 
prospective models. Current treatment options for juvenile justice involved youth are often 
time consuming and costly (Henggeler & Sheidow, 2012; Henggeler, 2003), and attempts to 
reduce illicit drug use in this high-risk sample have limited effectiveness (Watson, Greene, & 
Kelly, 2014; Grella, Hser, Joshi, & Rounds-Bryant, 2001). Treatments that target positive 
attitudes toward drug use in youth have resulted in reduced positive attitudes towards illicit 
drug use, alcohol use, and marijuana use (e.g., Mogro-Wilson, Letendre, Toi, & Bryan, 
2015; Tebes et al., 2007). It thus seems reasonable that such treatments could be combined, 
adapted, and validated for use in juvenile justice involved youth in order to target both drug 
use and positive attitudes toward drug use. Such treatment targets should then be empirically 
tested to see if they reduce the negative effects of CD symptoms in this high-risk group. 
Given the harmful combination of CD symptoms and illicit drug use in these youth, any 
method that can reduce illicit drug use in this high-risk group could be of high clinical 
relevance.
The present study is unique in highlighting the importance of positive attitudes toward illicit 
drug use as both a potential mechanism for the relationship between CD symptoms and 
illicit drug use for juvenile justice involved youth, and an important outcome of illicit drug 
use in this group. However, there are some limitations to discuss. First, the present study is 
cross-sectional in nature and thus no causal conclusions can be made; however, we view this 
study as a requisite step in research aimed at mitigating CD symptom risk on illicit drug use 
and illicit drug use attitudes in juvenile justice involved youth and our findings suggest 
feasibility of devoting resources to more complex and intensive longitudinal studies. Next, 
the majority of the participants were male, thus present findings may not generalize to 
females. Also, present findings used scale scores that examined multiple factors that 
contribute to both illicit drug use (e.g. quantity, frequency, social problems) and positive 
attitudes toward illicit drug use. There may be differential relationships between specific 
factors underlying these constructs that went undetected in the present study. Further, illicit 
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drug use was examined in general; differing results could be discovered if specific types of 
SUDs are tested, although it is important to note a majority of the sample reported a 
cannabis use disorder. Additionally, there are other factors that are potentially important to 
the relationships assessed in the present study, including age of onset of illicit drug use and 
peer illicit drug use. Future studies should examine these variables as potential moderating 
factors to detect risk indicators, for example, as earlier age of onset of drug use could be 
related to a stronger positive relationship between CD symptoms and illicit drug use or illicit 
drug use and positive attitudes towards illicit drug use. It should also be noted that both the 
YSR and the SASSI-A2 are subject to self-report bias, especially in the context of a court-
ordered psychological assessment when youth understand their answers will have an impact 
on the outcome of their current charges. At the same time, present findings were detected in 
light of this limitation. It should be noted that those youth not administered study measures 
were significantly younger than those youth included in the sample, thus findings may not 
generalize to younger juvenile justice involved youth.
5. Conclusion
It has been unclear how best to reduce negative outcomes associated with CD symptoms in 
juvenile justice involved youth. Overall, the current study provides initial evidence 
suggesting that positive attitudes toward illicit drug use both mediate the effects of CD 
symptoms on illicit drug use and are reinforced by illicit drug use in juvenile justice 
involved youth. This suggests the importance of targeting both illicit drug use and positive 
attitudes toward illicit drug use to reduce negative outcomes associated with CD symptoms 
in this high-risk group.
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Figure 1. 
Results of mediation models run using Andrew Hayes process macro (Hayes, 2013), 
controlling for age, gender, and race. Top: Results indicated that the indirect effect of CD 
symptoms on illicit drug use through positive attitudes toward illicit drug use was significant 
(β = 0.16, CI 0.09 to 0.27; Test for indirect effect z = 4.17, p <.001). Bottom: Results 
indicated that the indirect effect of CD symptoms on positive attitudes toward illicit drug use 
through illicit drug use was significant (β = 0.20, CI 0.12 to 0.32; Test for indirect effect z = 
4.87, p <.001).
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